FDA issues alert for Zocor

The FDA warned of an increased potential of muscle injury from the cholesterol drug Zocor, aka simvastatin, especially at higher doses. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.